Article Versions Notes

Mbefo M, Berger A, Schouwey K, Gérard X, Kostic C, Beryozkin A, Sharon D, Dolfuss H, Munier F, Tran HV, et al. Enhancer of Zeste Homolog 2 (EZH2) Contributes to Rod Photoreceptor Death Process in Several Forms of Retinal Degeneration and Its Activity Can Serve as a Biomarker for Therapy Efficacy. International Journal of Molecular Sciences. 2021; 22(17):9331. https://doi.org/10.3390/ijms22179331

Mbefo, Martial, Adeline Berger, Karine Schouwey, Xavier Gérard, Corinne Kostic, Avigail Beryozkin, Dror Sharon, Hélène Dolfuss, Francis Munier, Hoai Viet Tran, and et al. 2021. "Enhancer of Zeste Homolog 2 (EZH2) Contributes to Rod Photoreceptor Death Process in Several Forms of Retinal Degeneration and Its Activity Can Serve as a Biomarker for Therapy Efficacy" International Journal of Molecular Sciences 22, no. 17: 9331. https://doi.org/10.3390/ijms22179331

Mbefo, M., Berger, A., Schouwey, K., Gérard, X., Kostic, C., Beryozkin, A., Sharon, D., Dolfuss, H., Munier, F., Tran, H. V., van Lohuizen, M., Beltran, W. A., & Arsenijevic, Y. (2021). Enhancer of Zeste Homolog 2 (EZH2) Contributes to Rod Photoreceptor Death Process in Several Forms of Retinal Degeneration and Its Activity Can Serve as a Biomarker for Therapy Efficacy. International Journal of Molecular Sciences, 22(17), 9331. https://doi.org/10.3390/ijms22179331